Penicillin-binding protein 2a (PbP 2a) expression accounts for the insusceptibility of methicillin-resistant Staphylocuccus aureus (MRSA) to β-lactam antibiotics. In this research, we employed computational strategies to challenge PbP 2a with series of fifty-five ‘ala-ala’ and ‘ala-pro’ sulphonamide-dipeptides. The binding stability of two compounds (labeled: 10i and 10n) with theoretical Ki in nM and μM ranges, for PbP 2a active and allosteric sites respectively, were investigated using molecular dynamics simulations. In addition, the results of the sensitivity of four strains of MRSA for compounds 10i and 10n obtained revealed the compounds at 10 μg/ml caused two isolates (S4 and S10) to revert to being susceptible. Finally, a reliable binding conformation of both compounds in the two binding sites of PbP 2a are described to provide a rationale for structure-activity optimization of this series.
We are working on a new version of the website! To complete the upgrade, Sciforum will be unavailable on Saturday 18 July from 09:00 to 15:00 CEST. Thank you for your understanding.
Previous Article in event
Next Article in event
New Sulphonamide-peptide Hybrid Molecules as Potential PBP 2a Ligands and Methicillin Resistant Staphylococcus aureus Actives
Published:
04 November 2024
by MDPI
in 2nd Canadian Peptide and Protein Community Virtual Meeting
session Poster Session
Abstract:
Keywords: Sulphonamides; peptides; PbP 2a; MRSA; molecular docking; molecular dynamics; simulation; binding mode prediction; protein-ligand interaction
